Alzheimer’s researchers — or the public relations machines breathlessly trumpeting their work — should chill out. I see so much of this type of Alzheimer’s news that it’s hard to...
Clinical Briefs for Tuesday, September 24
By
Alicia Lasek
Sep 23, 2019
Long-term study of nurses links nut consumption with improved health … Alzheimer’s vaccine performs well in phase 2 trial … Gum disease linked to higher risk of hypertension … Simple lifestyle...
Clinical briefs for Thursday, April 7
By
Amy Novotney
Apr 07, 2022
Virtual dementia care program leads to 60% reduction in hospital admissions: study … Biden Administration accelerates effort to prevent, detect and treat Long COVID … BA.2 now behind 72% of all US...
Clinical briefs for Friday, Feb. 18
By
Amy Novotney
Feb 18, 2022
CDC reforming COVID-19 guidance … Nearly three-quarters of the U.S. now estimated to be immune to omicron variant … Brain synapse destruction culprit behind Alzheimer’s cognitive decline … Treatment...
Clinical briefs for Tuesday, Sept. 19
By
Kristen Fischer
Sep 19, 2023
Here’s how many nursing homes can meet proposed staffing requirements … Slim reimbursement for lumbar puncture an obstacle for Alzheimer’s care … Health, food policies could aid antimicrobial resistance...
Evaluating ‘Still Alice’
By
Elizabeth Newman
Feb 18, 2015
Much like Amour a few years ago, it’s not unrealistic for those who work or write about long-term care to feel as if the last thing they want to do is spend two hours watching a movie about illness,...
Glen Campbell Alzheimer’s documentary brings out the stars — caregivers and celebrities alike
By
James M. Berklan
Oct 22, 2014
As readers of this blog may recall, my expectations for the special screening of the new documentary about music superstar Glen Campbell’s journey with Alzheimer’s disease were high. Sunday...
Clinical briefs for Friday, Sept. 11
By
Kimberly Marselas
Sep 10, 2020
Urinary culture intervention leads to fewer antibiotic prescriptions … Sleep apnea tied to higher spine fracture risk in women … Scientists: Quiet zones in indoor spaces like dining rooms may limit...
U.S. lawmakers ramp up scrutiny of FDA following agency’s approval of controversial Alzheimer’s drug
By
Alicia Lasek
Sep 07, 2021
The FDA is being asked to help explain how Aduhelm (aducanumab) met accelerated approval criteria when so many experts — including internal advisers — have flagged insufficient safety and efficacy...
Vigorous exercise may guard against death from Alzheimer’s disease
By
Kristen Fischer
Dec 18, 2023
Engaging in vigorous activity compared to moderate exercise may lower the rate of dying from Alzheimer’s disease, according to a new study. The study was published in the December issue of The Lancet...